Sixth Street Partners Management Company »

Denali Therapeutics shares owned by Sixth Street Partners Management Company

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Sixth Street Partners Management Company from 13F filings

Historical chart of Sixth Street Partners Management Company investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Sixth Street Partners Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Sixth Street Partners Management Company

Quarter filed Position value Share count Share price at filing
2026-06-30 $32M 1.2M 25.72

More positions owned by Sixth Street Partners Management Company

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Schwab Strategic Tr Fundamental Us L (FNDX)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
UnitedHealth (UNH)
Tesla Motors (TSLA)
Micron Technology (MU)
Schwab Strategic Tr Fundamental Intl (FNDF)
Eli Lilly & Co. (LLY)
Home Depot (HD)

View all positions for Sixth Street Partners Management Company

Top funds holding Denali Therapeutics

BlackRock
Baillie Gifford & Co
Temasek Holdings
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
FMR
Goldman Sachs Group
Geode Capital Management
Holocene Advisors
Baker Bros. Advisors
Ubs Global Asset Management Americas
UBS Group
Alliancebernstein
Dimensional Fund Advisors

View all funds holding Denali Therapeutics